2,093
Views
4
CrossRef citations to date
0
Altmetric
Articles

Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting

, , , , , , , , & show all
Pages 487-492 | Received 20 Apr 2020, Accepted 20 Aug 2020, Published online: 08 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christian Beisland. (2020) Cytoreductive nephrectomy in primary metastatic clear cell renal cell carcinoma. Scandinavian Journal of Urology 54:6, pages 500-500.
Read now

Articles from other publishers (3)

Hana Studentova, Martina Spisarova, Andrea Kopova, Anezka Zemankova, Bohuslav Melichar & Vladimir StudentJr.Jr.. (2023) The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma. Cancers 15:15, pages 3855.
Crossref
Stamatios Katsimperis, Lazaros Tzelves, Themistoklis Bellos, Konstantinos Pikramenos, Ioannis Manolitsis, Ioannis Tsikopoulos & Iraklis Mitsogiannis. (2022) Cytoreductive nephrectomy for synchronous metastatic renal cell carcinoma. Is there enough evidence?. Archivio Italiano di Urologia e Andrologia 94:4, pages 476-485.
Crossref
Maite Emaldi & Caroline E. Nunes-Xavier. (2022) B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells. Cells 11:9, pages 1448.
Crossref